Akoya Biosciences Inc (AKYA)
2.42
-0.71
(-22.68%)
USD |
NASDAQ |
Nov 15, 10:48
Akoya Biosciences Free Cash Flow: -53.61M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -53.61M |
| March 31, 2024 | -55.62M |
| December 31, 2023 | -54.55M |
| September 30, 2023 | -59.25M |
| June 30, 2023 | -60.62M |
| March 31, 2023 | -62.35M |
| December 31, 2022 | -60.86M |
| September 30, 2022 | -57.20M |
| Date | Value |
|---|---|
| June 30, 2022 | -56.51M |
| March 31, 2022 | -54.92M |
| December 31, 2021 | -41.16M |
| September 30, 2021 | -36.58M |
| June 30, 2021 | -23.91M |
| March 31, 2021 | -13.10M |
| December 31, 2020 | -10.14M |
Free Cash Flow Range, Past 5 Years
-62.35M
Minimum
Mar 2023
-10.14M
Maximum
Dec 2020
-46.69M
Average
-54.92M
Median
Mar 2022
Free Cash Flow Benchmarks
| Bruker Corp | 156.70M |
| Azenta Inc | 40.93M |
| Harvard Bioscience Inc | 0.16M |
| Bionano Genomics Inc | -106.10M |
| Singular Genomics Systems Inc | -77.98M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.04M |
| Cash from Investing (Quarterly) | 9.054M |
| Cash from Financing (Quarterly) | -2.125M |
| Free Cash Flow Per Share (Quarterly) | -0.2269 |
| Free Cash Flow to Equity (Quarterly) | -11.43M |
| Free Cash Flow to Firm (Quarterly) | -9.266M |
| Free Cash Flow Yield | -44.92% |